Loading...
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
We summarised four pivotal Randomised Controlled Trials (RCTs) with antirheumatic drugs on the secondary prevention of cardiovascular events. The favourable effects of canakinumab and colchicine confirm (low-grade) inflammation as an independent risk factor for cardiovascular events. While colchicin...
Na minha lista:
| Udgivet i: | RMD Open |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970260/ https://ncbi.nlm.nih.gov/pubmed/33727219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001560 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|